GBR 12935 dihydrochloride,
67469-81-2,
GBR-12935 dihydrochloride,
GBR 12935 (dihydrochloride),
1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride,
MFCD00083175,
1-(2-DIPHENYLMETHOXYETHYL)-4-(3-PHENYLPROPYL)PIPERAZINE DIHYDROCHLORIDE,
GBR 12935 HCl,
CHEBI:64091,
1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride,
1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)-piperazine dihydrochloride,
1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazinediium dichloride,
SR-01000075429,
1-(2-(Benzhydryloxy)ethyl)-4-(3-phenylpropyl)piperazine dihydrochloride,
76778-22-8,
EU-0100560,
GBR12935 dihydrochloride,
GBR12935(dihydrochloride),
C28H34N2O.2ClH,
SCHEMBL339982,
GBR-12935 2HCl,
CHEMBL1330764,
DTXSID6042573,
CTK8G0008,
KS-00001CWV,
AOB2532,
EX-A451,
BCP09762,
Tox21_500560,
3692AH,
BN0221,
AKOS024458512,
AN-3496,
CCG-221864,
CS-3130,
LP00560,
NCGC00093945-01,
NCGC00261245-01,
4CA-0553,
AK326672,
HY-12242,
LS-111942,
FT-0726457,
G 9659,
C-55147,
SR-01000075429-1,
SR-01000075429-3,
GBR 12935 dihydrochloride, >=98% (TLC), powder,
1-(2-benzhydryloxyethyl)-4-(3-phenylpropyl)piperazine dihydrochloride,
1-(2-benzhydryloxyethyl)-4-(3-phenylpropyl)piperazine;dihydrochloride,
1-(2-DIPHENYLMETHOXYETHYL)-4-(3-PHENYLPROPYL)PIPERAZINE 2HCL,
Piperazine,1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)-, hydrochloride (1:2),
GBR-12935,
Gbr 12935,
NQWRSILGEXNJIT-UHFFFAOYSA-N,
GBR12935,
CID11957553,
1- -4- PIPERAZINEDIHYDROCHLORIDE,
67469-81-2 (HCl),
B4661,
A11937,